期刊文献+

SonoVue与Sonazoid高频条件下对兔肝显像效果的对比分析 被引量:2

Comparison of the imaging effects of SonoVue and Sonazoid at high frequency in rabbit-liver ultrasonography
原文传递
导出
摘要 目的探讨两种超声造影剂不同剂量和机械指数(MI)条件下的显像效果。方法分别对8只新西兰大白兔多次团注超声造影剂SonoVue(0.06ml/kg、0.12ml/kg)及Sonazoid(0.045ml/kg、0.09ml/kg),SonoVue组每个剂量水平分别设置7个MI值(O.10~0.55),Sonazoid组每个剂量水平分别设置5个MI值(O.19~0.98)。应用视频密度分析软件对显像过程做定量分析,并比较其峰值强度(PI)。结果在相同发射频率(7MHz)条件下:SonoVue组不同剂量组PI值均于MI=0.15时达最大值(P〈0.05);相同MI下,高剂量组PI值较大。Sonazoid组不同剂量组PI值均于MI=0.40时达最大值(P〈0.05);相同MI下,高剂量组PI值较大。结论SonoVue与Sonazoid显像条件不同,临床使用中需兼顾造影剂剂量、MI值及频率的影响。 Objective To compare the contrast enhancement effects of SonoVue and Sonazoid in rabbit liver at ultrasonic frequency of 7 MHz using various mechanical index(MI) and dosage. Methods Eight rabbits were bolus injected with different contrast agents:for SonoVue(0.06 ml/kg,0.12 ml/kg),MI ranging 0.10 - 0.55 ; while Sonazoid (0. 045 ml/kg, 0.09 ml/kg), MI ranging 0.19 - 0.98. Quantitative analysis of ultrasonography was done using video-intensity analysis system, and peak intensity (PI) was compared. Results With the same frequency, in SonoVue group, for both dosage groups, PI reached maximum at MI= 0.15 (P 〈0.05); with the same MI, PI of the high dosage group was higher (P〈0.05). In Sonazoid group,for both dosage groups,PI reached maximum at MI = 0.40( P 〈0.05) ;with the same MI,PI of the high dose group was higher ( P 〈0.05). Conclusions The optimistic ultrasonographic conditions provided to SonoVue and Sonazoid are different. Dosage of contrast agents, MI and frequency need to be concerned.
出处 《中华超声影像学杂志》 CSCD 北大核心 2011年第4期344-347,共4页 Chinese Journal of Ultrasonography
关键词 超声检查 微气泡 Ultrasonography Microbubbles Liver
  • 相关文献

参考文献18

  • 1Liu H,Jiang YX,Liu JB, et al. Evaluation of breast lesions with contrast-enhanced ultrasound using the microvascular imaging technique: initial observations. The Breast, 2008, 17 : 532-539.
  • 2Ferrari FS, Megliola A, Scorzelli A, et al. Ultrasound examination using contrast agent and elastosonography in the evaluation of single thyroid nodules: Preliminary results. J Ultrasound,2008,11 : 47-54.
  • 3Wang Y, Wang W, Li J, et al. Gray-scale contrast-enhanced ultrasonography of sentinel lymph nodes in a metastatic breast cancer model. Aead Radiol, 2009,16 : 957-962.
  • 4Kettenbach J, Helbich TH, Huber S, et al. Computer-assisted quantitative assessment of power Doppler US: effects of microbubble contrast agent in the differentiation of breast tumors. Eur J Radiol,2005,53:238- 244.
  • 5Stride E, Tang MX, Eckersley RJ. Physical phenomena affecting quantitative imaging o{ ultrasound contrast agents. Appl Acoust, 2009,70:1352-1362.
  • 6Whittingham TA. WFUMB safety symposium on echo-contrast agents:exposure from diagnostic ultrasound equipment relating to cavitation risk. Ultrasound Med Bioi, 2007,33 : 214-223.
  • 7Bouakaz A, de Jong N. WFUMB safety symposium on echocontrast agents: nature and types of ultrasound contrast agents. Ultrasound Med Biol, 2007,33 : 187-196.
  • 8Chomas JE,Dayton P, May D, et al. Threshold of fragmentation for ultrasonic contrast agents. J Biomed Opt, 2001,6 : 141-150.
  • 9Yasui K,Lee J, Tuziuti T, et al. Influence of the bubble-bubble interaction on destruction of encapsulated microbubbles under ultrasound. J Acoust Soc Am, 2009,126 : 973-982.
  • 10李杰,董宝玮,于晓玲,王兴华.肝灰阶超声造影剂量与效果关系的实验研究[J].中华超声影像学杂志,2004,13(7):547-550. 被引量:23

二级参考文献6

  • 1Lee E, Angerson WJ, Yarmenitis S, et al. Multi-center clinical study evaluating the efficacy of SonoVueTM (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol, 2002,41 : 200-206.
  • 2Maruyama H, Matsutani S, Saisho H, et al. Gray-scale contrast enhancement in rabbit liver with DMP115 at different acoustic power levels. Ultrasound Med Biol, 2000,26:1429-1438.
  • 3Madjar H, Prompeler HJ, Favero CD, et al. A new Doppler signal enhancing agent for flow assessment in breast lesions. Eur J Ultrasound, 2000,12:123-130.
  • 4Seides G, Meyer K, Algermissen C, et al. Harmonic imaging of the brain parenchyma using a perfluorobutane-containing ultrasound contrast agent. Ultrasound Med Biol, 2001,27:915-918.
  • 5Bos LJ, Piek JJ, Vergroesen I, et al. Confounding effects of myocardial background intensity and attenuation in contrast echocardiography: an in vivo study. Ultrasound Med Biol, 1999,25:1177-1184.
  • 6罗福成,童清平,陈训,连娟,裴红,章仁品,叶玉玲.多普勒能量显像在肝脏肿瘤血流检测中的方法学探讨[J].中国医学影像技术,2001,17(9):894-895. 被引量:2

共引文献27

同被引文献10

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部